Healthcare provider profile · identity verified

Eric J. Crisostomo, MD

Internal Medicine · FAIRFIELD, CA · NPI 1689752412

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	580	196
Amlodipine Besylate	Amlodipine Besylate	376	128
Lisinopril	Lisinopril	295	101
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	266	32
Losartan Potassium	Losartan Potassium	250	81
Levothyroxine Sodium	Levothyroxine Sodium	244	67
Albuterol Sulfate Hfa	Albuterol Sulfate	226	86
Tamsulosin Hcl	Tamsulosin Hcl	207	63
Fluticasone Propionate	Fluticasone Propionate	199	76
Atenolol	Atenolol	193	59
Hydrochlorothiazide	Hydrochlorothiazide	188	61
Trazodone Hcl	Trazodone Hcl	176	38
Metformin Hcl	Metformin Hcl	157	49
Metoprolol Tartrate	Metoprolol Tartrate	152	47
Famotidine	Famotidine	129	41
Ibuprofen	Ibuprofen	127	44
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	119	13
Simvastatin	Simvastatin	118	35
Pantoprazole Sodium	Pantoprazole Sodium	112	38
Glipizide	Glipizide	100	36
Allopurinol	Allopurinol	89	34
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	88	30
Metoprolol Succinate	Metoprolol Succinate	86	29
Gabapentin	Gabapentin	84	29
Lovastatin	Lovastatin	78	26
Furosemide	Furosemide	72	23
Omeprazole	Omeprazole	69	21
Alendronate Sodium	Alendronate Sodium	68	22
Alvesco	Ciclesonide	63	28
Pradaxa	Dabigatran Etexilate Mesylate	61	15
Tizanidine Hcl	Tizanidine Hcl	58	24
Montelukast Sodium	Montelukast Sodium	57	18
Metformin Hcl Er	Metformin Hcl	53	22
Triamcinolone Acetonide	Triamcinolone Acetonide	53	28
Wixela Inhub	Fluticasone Propion/Salmeterol	52	13
Terazosin Hcl	Terazosin Hcl	48	16
Hydrocortisone	Hydrocortisone	47	24
Fluoxetine Hcl	Fluoxetine Hcl	45	16
Potassium Chloride	Potassium Chloride	44	17
Doxycycline Monohydrate	Doxycycline Monohydrate	42	28
Nabumetone	Nabumetone	40	suppressed
Tramadol Hcl	Tramadol Hcl	40	suppressed
Carvedilol	Carvedilol	39	16
Clopidogrel	Clopidogrel Bisulfate	37	13
Finasteride	Finasteride	37	14
Meloxicam	Meloxicam	37	suppressed
Fluocinonide	Fluocinonide	36	21
Prednisone	Prednisone	36	25
Acetaminophen-Codeine	Acetaminophen With Codeine	35	suppressed
Ondansetron Odt	Ondansetron	33	suppressed
Sertraline Hcl	Sertraline Hcl	33	11
Pravastatin Sodium	Pravastatin Sodium	31	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	31	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	11
Bupropion Xl	Bupropion Hcl	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	27	27
Dicyclomine Hcl	Dicyclomine Hcl	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	14
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Duloxetine Hcl	Duloxetine Hcl	25	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Jardiance	Empagliflozin	25	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	25	suppressed
Breyna	Budesonide/Formoterol Fumarate	24	suppressed
Glipizide Er	Glipizide	24	suppressed
Lorazepam	Lorazepam	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	24	11
Humulin N	Insulin Nph Human Isophane	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Nitroglycerin	Nitroglycerin	22	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	16
Chlorthalidone	Chlorthalidone	21	suppressed
Colchicine	Colchicine	21	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	20	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Nystatin	Nystatin	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	19	suppressed
Humulin R	Insulin Regular, Human	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Varenicline Tartrate	Varenicline Tartrate	19	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	16
Warfarin Sodium	Warfarin Sodium	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	17	suppressed
Carbamazepine	Carbamazepine	16	suppressed
Lactulose	Lactulose	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Naproxen	Naproxen	15	12
Phenobarbital	Phenobarbital	15	suppressed
Azithromycin	Azithromycin	14	12
Buspirone Hcl	Buspirone Hcl	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	suppressed
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Digoxin	Digoxin	12	suppressed
Ozempic	Semaglutide	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Baclofen	Baclofen	11	suppressed
Buprenorphine	Buprenorphine	11	suppressed
Cefadroxil	Cefadroxil	11	suppressed
Glucagon Emergency Kit	Glucagon	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error